What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Microbiology
Joseph Meletiadis spends much of his time researching Microbiology, Itraconazole, Posaconazole, Pharmacology and Amphotericin B.
His Itraconazole research incorporates elements of Dermatology and Voriconazole.
His Posaconazole research is multidisciplinary, incorporating perspectives in Mucormycosis, Amphotericin B deoxycholate and Intensive care medicine.
His work on Drug interaction as part of general Pharmacology study is frequently linked to In vivo, therefore connecting diverse disciplines of science.
His Amphotericin B study integrates concerns from other disciplines, such as Fluconazole, Chromoblastomycosis, Pathology, Pathognomonic and Mycosis.
The Aspergillus fumigatus study combines topics in areas such as Aspergillosis and Aspergillus flavus.
His most cited work include:
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)
- Infections Caused by Scedosporium spp. (498 citations)
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others (269 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Microbiology, Aspergillus fumigatus, Pharmacology, Voriconazole and Pharmacodynamics.
His study in Amphotericin B, Itraconazole, Aspergillus, Aspergillus terreus and Aspergillus flavus is carried out as part of his Microbiology studies.
His work carried out in the field of Itraconazole brings together such families of science as Agar and Scedosporium prolificans.
His study on Aspergillus fumigatus also encompasses disciplines like
- Aspergillosis together with Neutropenia and Mycosis,
- Caspofungin which is related to area like Micafungin.
In the subject of general Pharmacology, his work in Combination therapy is often linked to In vivo, thereby combining diverse domains of study.
His work on Anidulafungin as part of his general Voriconazole study is frequently connected to Fungal protein, thereby bridging the divide between different branches of science.
He most often published in these fields:
- Microbiology (80.87%)
- Aspergillus fumigatus (36.07%)
- Pharmacology (34.43%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (80.87%)
- Pharmacodynamics (42.62%)
- Pharmacokinetics (28.96%)
In recent papers he was focusing on the following fields of study:
His main research concerns Microbiology, Pharmacodynamics, Pharmacokinetics, Posaconazole and Itraconazole.
His Microbiology research incorporates themes from Pseudomonas aeruginosa and Klebsiella pneumoniae.
His work on PK/PD models as part of general Pharmacodynamics study is frequently linked to In vivo, bridging the gap between disciplines.
His studies in Posaconazole integrate themes in fields like Amphotericin B deoxycholate, Guideline, Fluconazole, Intensive care medicine and Mucormycosis.
His Itraconazole study which covers Voriconazole that intersects with Amphotericin B.
He focuses mostly in the field of Aspergillus fumigatus, narrowing it down to topics relating to Azole and, in certain cases, Agar plate.
Between 2018 and 2021, his most popular works were:
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
- How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates (35 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Microbiology
Joseph Meletiadis mainly focuses on Microbiology, Itraconazole, Posaconazole, Voriconazole and Internal medicine.
Posaconazole is a primary field of his research addressed under Amphotericin B.
His work deals with themes such as Agar plate, Azole, Aspergillus fumigatus, Agar and Aspergillosis, which intersect with Voriconazole.
His Internal medicine research is multidisciplinary, incorporating elements of Drug and Fluconazole, Micafungin.
His Fluconazole study combines topics in areas such as Candida glabrata and Candida tropicalis.
His Anidulafungin study incorporates themes from Genetic diversity, Molecular epidemiology and Aspergillus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
